Small Cap Feast
Small Cap Feast – 20th April 2017
Dish of the Day:
No AIM Joiners Today
No AIM Joiners Today
Off the Menu:
NO AIM Leavers Today
NO AIM Leavers Today
What’s Cooking in the IPO Kitchen?
Global Ports Holding—Intention to float on Standard List. International cruise ports operator. Seeking $250m raise including $75m primary offer.
Dorcaster—Schedule One Update. Admission now expected 3 May. RTO of Escape Hunt raising £14m at 135p
Verditek— Intention to float on AIM. On Admission, the Company’s subsidiaries will be involved in advanced solar photovoltaic, filtration and absorption technologies specialising in providing environmental services. Raising £3.5m. Admission in May.
Eddie Stobart Logistics— Schedule 1 update. Admission expected 25 April raising £122m.
ADES International Holding— Intends to join the Standard List in May raising up to $170m plus a vendor sale. Provider of offshore and onshore oil and gas drilling and production services in the Middle East and Africa. Admission expected in May.
Tufton Oceanic Assets– Offer extended to 9 May to enable investors to complete further due diligence.
Ortac Resources (OTC.L) 3.13p £2.57m
The mineral exploration company operating in Europe and Africa, entered into an agreement to form a joint venture with a Slovakian company to jointly develop the Sturec Gold Project at Kremnica. The Sturec project has a reserve of just under 900,000 oz gold equivalent which has progressed to pre-feasibility stage. Meanwhile the process for final validation of the underground mining license as announced on 17 March 2017 continues on track.
Anglo African Oil & Gas (AAOG.L) 27.5p £14.62m
The independent oil and gas developer, has agreed terms to contract the wireline and ancillary equipment for the workover that is intended to undertake the reperforation and acidisation of the R2 reservoir in well TLP-102. The objective of this workover is to bring this well into production at a rate of up to 100 barrels of oil per day. The equipment is anticipated to arrive at the Tilapia field and commence operations on 8 May 2017. The Company will make further announcements in due course, including as to the results of this workover and plans for the workover of TLP-101 and drilling of the new well, TLP-103.
Braveheart Investment Group (BRH.L) 15p £4.06m
Trading update from the fund management and strategic investor group. The Group has continued to perform in line with the January 2017 trading update and, as a consequence, the Directors expect that profit before and after taxation for the y/e March17 will be c. £750k. As opportunities have arisen, the Group has continued to invest in its strategic investment portfolio and has resulted in an increase its percentage holding in Kirkstall from 28 per cent. to 37 per cent. and following the purchase of existing shares and the provision of a convertible loan to Paraytec, the Group’s interest would increase, on conversion, from 33 per cent. to 47 per cent. “We are pleased with our progress over the past year and have cash on our balance sheet available for further investment opportunities over the coming months.”
Cluff Natural Resources(CLNR.L) 2.65p £8.73m
The natural resources investing company announced results of an independent Scoping Study covering two prospects on its 100% owned Licence P2248 in the Southern North Sea gas basin, which has seen a significant pick-up in operational and corporate activity. Post drill Expected Monetary Value (‘EMV’) following a discovery for Cadence & Basset of £86.6m & £69m respectively. Implied extrapolated un-risked NPV for the 6 identified prospects on Licence P2248 of £697m. ‘Should exploration wells prove commercial quantities of gas in line with expectations, then the Scoping Study economics demonstrate that cost effective development options are readily available, a key consideration for any operator or investor looking at the Company’s exploration assets.’
Walker Greenbank (WGB.L) 213.5p £149.5m
Thee luxury interior furnishings group, announces has received a further interim insurance payment of £1.5 million following the flood in December 2015 at Standfast & Barracks, the Company’s fabric printing factory in Lancaster. In total, £16.9 million of flood-related insurance payments have now been received by the Company in respect of damage to business assets and loss of profits. With the factory having been back in full production for some time and the Company’s Milton Keynes warehouse being fully stocked with printed textiles, the Company will be seeking to negotiate a final settlement of the insurance claim with its insurers. It is expected that a settlement will be agreed during the first half of the current financial year. FY Jan 18 rev £122.2m PBT £14.2m.
Modern Water (MWG.L) 9.88p £7.85m
The owner of world-leading technologies for water and wastewater treatment and for water quality monitoring, has secured a sale of its proprietary Forward Osmosis (“FO”) technology for seawater desalination to Hangzhou Water in China. The Company will license its patented FO technology and provide its extensive engineering know-how to Hangzhou Water, for use in a new 500m3/day seawater desalination plant, to be built at the Shengsi Seawater Desalination Base on Sijiao Island. Modern Water will receive licence fees in the short term; and commissioning fees for supervising commissioning of the plant; as well as selling Hangzhou Water specialised equipment and spares on a long term basis. Expected plant completion early 2018.
Paragon Entertainment (PEL.L) 5.12p £9.62m
FYDec16 results from the attractions design, production and fit-out business. Revenue +70% to £14.4m. Gross profit up 91% to £3.8m. Ebitda of £1.19m vs £0.24m. Earnings down to £0.31m from £0.6m following a goodwill write down. Net cash of £1.2m from a £0.2m deficit. ‘In 2017, we expect that £7 million of our turnover will come from repeat partnership business, amounting to approximately 45% of our revenue guidance of £15.7 million for 2017 and we anticipate our work to have the following geographical split: 20% UK, 10% Europe, 65% MENA and 5% China.’
Action Hotels (AHCG.L) 46p £67.91m
FYDec16 trading update from g owner, developer, and asset manager of branded three and four-star hotels in the Middle East and Australia. The Company expects to report total revenue increased by c.22% to approximately $53.1m adjusted EBITDA + c.16% to approximately $18.5m and the value of Action Hotels’ hotel assets increased by c.15% to approximately $458m. As is typical in many development companies, Experienced some unforeseen delays in opening dates of some of its new hotels and this has negatively impacted revenue resulting in a level that is materially below market expectations. Divi to remain in line. Trading in Q1 2017 is solid with total revenue up c.14% over the same period last year.
Redx Pharma (REDX.L) 35p £45.37m
The research and development company focused on cancer, immunology and infection, has appointed Iain Ross as Non-exec Chairman effective from 1st May. Mr Ross has over 35 years’ of experience having held Senior Board and Management positions at multiple public and private companies in the life sciences sector. Currently Mr Ross serves as Non-Executive Chairman of AIM quoted e-Therapeutics plc and Biomer Technology Ltd alongside his Non-Executive Directorships at London listed Premier Veterinary Group plc, and ASX quoted Anatara LifeSciences Ltd and Novogen Ltd and as a Director of Aldershot Town Football Club.
Ebiquity (EBQ.L) 115p £88.78m
The independent marketing and media analytics consultancy, has announced the launch of Portfolio Digital, a new digital ad intelligence platform designed to monitor online display advertising. The UK launch follows the successful release of Portfolio Digital in Australia. Portfolio Digital allows subscribers to track competitors’ media strategy, messaging & tactics, including quantum and frequency of spending, how the ads appear in situ, and their position on the web pages where they appear. The platform includes a unique spend calculation model which provides an up to date estimation of actual expenditure. To be followed by Europe & US launches. PE 11.4x.
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email firstname.lastname@example.org with “unsubscribe me”.